Shanghai Securities News (Reporter Feng Xinyi) - West Point PharmaceuticalsThe company announced in a midday announcement on March 26 that it recently received the " Chemical Raw Material " certificate for ferric protein succinate issued by the National Medical Products Administration.Notification of Approval for Drug Marketing Application.
According to the announcement, ferric protein succinate is an iron supplement used for occult or overt iron deficiency anemia caused by insufficient iron intake or malabsorption, acute or chronic blood loss, and infection, as well as absolute and relative iron deficiency anemia such as anemia during pregnancy and lactation.
Westpoint Pharmaceuticals stated that the product approval further enriches the company's product line and helps enhance the market competitiveness of its products. However, due to the high-tech, high-risk, and high-value-added characteristics of pharmaceutical products, sales after approval are easily affected by factors such as changes in industry policies, bidding and procurement, and changes in the market environment, thus involving uncertainty. Investors are advised to make prudent decisions and pay attention to investment risks.

https://finance.eastmoney.com/a/202603263685280961.html